Non-Profit Accounting Senior Manager
About the job
- A bachelor's degree in Accounting, Finance, or a related field is required.
- A minimum of 5 years of accounting experience is required, including at least 2 years in a non-profit environment or working with charitable organizations.
- Strong understanding of non-profit accounting principles, including fund accounting, grants, and Internal Revenue Service regulations.
- Experience with financial reporting, budgeting, and forecasting in a non-profit or public company setting.
- Proficiency with accounting software, including experience with Oracle Fusion, and Microsoft Excel.
- Knowledge of auditing standards and experience coordinating audits.
- Strong analytical skills and attention to detail.
- Ability to work independently, manage multiple priorities, and meet deadlines.
- Excellent communication and interpersonal skills, with the ability to work effectively with diverse teams and stakeholders.
- Commitment to the mission and values of a non-profit charity organization.
- Oversee the accounting and financial operations of the non-profit charity, ensuring accuracy and compliance with accounting standards and regulations.
- Prepare and review financial statements, ensuring they accurately reflect the charity's financial position and performance.
- Monitor and reconcile accounts, including donations, restricted funds, and other revenue sources, ensuring proper recording and reporting.
- Ensure compliance with all non-profit regulatory and tax requirements, including Internal Revenue Service Form 990 and other necessary filings.
- Work closely with internal teams to assess and improve financial processes and controls.
- Coordinate with external auditors for audits and assist with the preparation of audit schedules and documentation.
- Provide financial analysis and reports to senior leadership, donors, and key stakeholders to support decision-making and strategic planning.
- Provide guidance and mentorship to accounting staff and volunteers as needed.
- Support the integration of the non-profit charity's financial systems with the broader financial operations of the publicly traded company.
- Certified Public Accountant credential.
About the company
BrightSpring Health Services delivers home and community-based health services for people with complex or chronic needs, organized into two segments: Pharmacy and Provider. The Pharmacy segment provides specialty, infusion, and community pharmacy services to patients with complex conditions. The Provider segment offers behavioral health, home health, hospice care, and services for individuals with intellectual and developmental disabilities. The company runs an integrated care model through a network of pharmacies and providers to support a continuum of care that includes clinical services, care coordination, and in-home support. Revenue comes from Medicare, Medicaid, and private insurance, reflecting reimbursement across public and private payers. The goal is to coordinate pharmacy and in-home health services to improve access, continuity, and outcomes for patients and to serve managed care organizations with a complete care solution.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Lyndon, Kentucky
Founded
1974
Get referred to BrightSpring Health Services
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue rose 23% to $3.873 billion, with EBITDA up 44%.
- Leverage fell to 2.15x on June 30, 2026, easing balance-sheet pressure.
- Management raised 2026 guidance to $15.1-$15.425 billion revenue and $820-$845 million EBITDA.
What critics are saying
- Home and Community Pharmacy lost $200 million to IRA in 2026.
- Home and Community Pharmacy revenue fell 8% in Q2 2026 after customer exits.
- FTC scrutiny around health-service consolidation raises execution risk if future deals invite challenge.
What makes BrightSpring Health Services unique
- Specialty and infusion pharmacy launched 12 LDDs through Q2 2026, driving access.
- BrightSpring completed Community Living divestiture on March 30, 2026, sharpening focus.
- Amedisys and LHC branches add $35 million EBITDA in 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↓ -4%1 year growth
↓ -4%2 year growth
↓ -4%Cardinal Health bets on At-Home Solutions growth. Cardinal Health (CAH) is positioning its At-Home Solutions business to capture the continued shift toward home-based healthcare, particularly through diabetes and other specialized care needs, according to a Zacks Investment Research analysis describing Cardinal Health At-Home Solutions growth as a central pillar of the company's near-term strategy. How management frames this Cardinal Health At-Home Solutions growth opportunity. Management described at-Home as a fast-growing yet fragmented market, creating opportunities to scale through both organic investments and acquisitions. The business delivered strong operating performance in the fourth quarter, supported by investments in distribution capacity, technology and automation, with a nearly 99% fill rate and its best-ever quarter for on-time departures. Why fragmentation creates acquisition opportunity. Describing the at-home care market as fragmented signals that no single company currently dominates the space, giving Cardinal Health room to consolidate smaller regional or specialized providers into its existing distribution infrastructure rather than competing purely on organic growth alone. The Diabetes Supply integration behind this Cardinal Health At-Home Solutions growth strategy. The integration of Advanced Diabetes Supply, or ADS, is becoming an important component of this strategy. Cardinal Health said the integration was progressing ahead of schedule on synergies, while recent investments in home care are strengthening the framework established through ADS. The company is also scaling through the completed acquisition of Strive Medical and the announced acquisition of AdaptHealth's Diabetes Health business. Why these acquisitions reinforce a single strategic focus. Concentrating multiple acquisitions specifically within diabetes and related home care supply chains suggests Cardinal Health is deliberately building depth in one clinical category rather than diversifying broadly across unrelated home health service lines. Cardinal Health's broader ecosystem connectivity within this At-Home Solutions growth push. Beyond distribution, Cardinal Health is building connectivity across the healthcare ecosystem. Its continued care pathway program simplifies diabetes supply management for both pharmacies and patients, allowing the company to extend its role beyond traditional product distribution. Financial targets for fiscal 2027. For fiscal 2027, management expects the Other growth businesses, which include At-Home Solutions, to deliver 11% to 13% revenue growth and 15% to 18% profit growth. The Zacks Consensus Estimate for Cardinal Health's fiscal 2027 earnings implies an 11.5% rise from the year-ago reported number. How competitors are positioned alongside this Cardinal Health At-Home Solutions growth trend. BrightSpring Health Services is expanding its at-home footprint through a platform spanning home health, hospice, personal care and home-based primary care, with Provider Services revenues increasing 30% in the second quarter, led by 51% Home Health Care revenue growth supported by census gains, de novo expansion and contributions from Amedisys and LHC branches. Addus HomeCare is expanding primarily through Personal Care, with revenues rising 6.8% in the second quarter, and has expanded into Indiana through HomeCourt Home Care while agreeing to acquire another Indianapolis-area provider. Why this competitive backdrop matters. The presence of well-capitalized competitors like BrightSpring and Addus, each pursuing their own acquisition-driven growth strategies within adjacent home care segments, suggests Cardinal Health's at-home push is occurring within an increasingly active consolidation environment across the broader home-based care industry. Cardinal Health's stock performance and valuation within this report. Shares of CAH have gained 7.1% so far this year compared with the industry's 2% growth. Cardinal Health trades at a forward price-to-earnings of 17.1X, above the industry average, though lower than its five-year high of 22.19X. The company carries a Value Score of A and a Zacks Rank #3 (Hold). What this rating signals. A Zacks Rank #3 (Hold) indicates the firm's analysts view CAH as likely to perform roughly in line with the broader market rather than significantly outperforming or underperforming it, a more neutral assessment than the stock's above-average year-to-date gain might otherwise suggest. What this Cardinal Health At-Home Solutions growth strategy means going forward. With the Strive Medical acquisition already completed and the AdaptHealth Diabetes Health deal still pending, Cardinal Health's near-term ability to hit its stated 11% to 13% revenue growth target for its Other growth businesses segment will depend partly on how smoothly these acquisitions integrate alongside the already-underway ADS synergies. Given the competitive activity from BrightSpring and Addus HomeCare in adjacent home care segments, Cardinal Health's success in the fragmented at-home market may depend on how effectively it differentiates its diabetes-focused strategy from these broader-service competitors. What to watch going forward. As Cardinal Health moves toward closing its AdaptHealth Diabetes Health acquisition, investors will likely watch whether the company's fiscal 2027 guidance holds up and whether its Hold rating shifts as more integration results become available. Given the broader industry trend of consolidation across home health, hospice, and personal care reflected in BrightSpring's and Addus's own acquisition activity, this Cardinal Health At-Home Solutions growth strategy may continue to be judged against how well its diabetes-focused, distribution-centered approach performs relative to peers pursuing broader home-based care platforms. This analysis reflects Zacks' own research and ratings; readers considering any investment decision should consult a licensed financial advisor.
BrightSpring Health Services stands out as a strong long-term healthcare investment, whilst Solventum and Inspire Medical Systems face headwinds, according to recent analysis. Healthcare stocks have surged 27.5% over the past six months, outperforming the S&P 500 by 16.2 percentage points. However, increased venture capital has intensified competition across the sector. BrightSpring, which provides home health care, hospice, and pharmacy services, has achieved 23.9% annual revenue growth over the past two years. Analysts forecast 14.1% revenue growth for the next 12 months. Conversely, Solventum faces weak demand with flat revenue expected, whilst its free cash flow margin has declined 18.2 percentage points over five years. Inspire Medical Systems confronts a forecasted revenue decline of 3.5% for the upcoming year.
Two companies leverage profitability to outpace competitors, whilst another faces headwinds, according to StockStory's analysis. Primoris, which builds and maintains infrastructure in utility, energy, and civil construction sectors, struggles with a low gross margin of 10.3% reflecting high production costs. The company has seen falling earnings per share over two years and weak free cash flow margin of 2.2% over five years. BrightSpring Health Services, offering home health care and pharmacy services, has posted 23.9% annual revenue growth over two years. Its revenue base of $14.37 billion provides economies of scale. Pfizer's massive $63.7 billion revenue base gives it significant negotiating power. The pharmaceutical giant's adjusted operating margin expanded by 18.5 percentage points over two years, whilst delivering a 17.5% return on capital.
BrightSpring Health Services exceeded Wall Street expectations in Q2, delivering revenue of $3.87 billion and adjusted earnings per share of $0.45, beating analyst estimates by 5.9% and 13% respectively. The company's Specialty and Infusion pharmacy business drove growth, with revenue up 30% and script growth of 31% year-over-year. CEO Jon Rousseau attributed the performance to new limited distribution drug launches and broad-based volume growth. However, segments like Home and Community Pharmacy faced challenges from customer exits and regulatory headwinds. The company raised its full-year revenue guidance to $15.26 billion at the midpoint, up 1.9% from previous guidance. Operating margin improved to 3.4%, compared to 1.5% in the prior-year quarter. Despite the strong results, the market reacted negatively, reflecting concerns about underlying business headwinds.
Micron Technology, BrightSpring Health Services, and Custom Truck One Source have emerged as standout profitable stocks based on strong net income ratios and growth prospects. The selection criteria included a Zacks Rank of #1, trailing 12-month sales and net income growth exceeding industry averages, and a net income ratio higher than the industry standard. Micron Technology, a global memory and storage provider, shows particularly impressive metrics with a 12-month net profit margin of 55.9%. The company's expected earnings growth rate for the current year stands at 791%. The screening process, using the Zacks Research Wizard, filtered more than 7,685 stocks down to just 13 that met all criteria. The net income ratio helps investors assess a company's ability to cover both operating and non-operating expenses with revenues.